Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28835803 | 0.79 | HTT (0.34) | — | |
| SCHEMBL6683147 | 0.74 | KDM4E (0.32) | — | |
| SCHEMBL20971279 | 0.73 | MEN1 (0.34) | MEN1KMT2A | |
| SCHEMBL186811 | 0.71 | MEN1 (0.33) | MEN1KMT2A | |
| SCHEMBL9481009 | 0.70 | MEN1 (0.32) | MEN1KMT2A | |
| SCHEMBL22117654 | 0.68 | MEN1 (0.30) | MEN1KMT2A | |
| SCHEMBL9077347 | 0.67 | MEN1 (0.35) | MEN1KMT2A | |
| SCHEMBL23793326 | 0.67 | MAPK1 (0.32) | MEN1KMT2A | |
| SCHEMBL5704683 | 0.67 | MEN1 (0.32) | MEN1KMT2A | |
| SCHEMBL28891086 | 0.67 | MEN1 (0.32) | MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040249147-A1 | Synthesis of key azole-antifungal intermediates | RANBAXY LABORATORIES LIMITED (IN) | 2004-12-09 | — | — | US | disclosed |
| EP-1432704-A1 | SYNTHESIS OF KEY AZOLE-ANTIFUNGAL INTERMEDIATES | RANBAXY LABORATORIES, LTD. (IN) | 2004-06-30 | — | — | EP | disclosed |
| WO-2003027103-A1 | SYNTHESIS OF KEY AZOLE-ANTIFUNGAL INTERMEDIATES | RANBAXY LABORATORIES LIMITED (IN) | 2003-04-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040249147-A1 | Synthesis of key azole-antifungal intermediates | ERG28, CYP11B1, CYP2E1 | MEN1 112/4885KMT2A 817/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.